Dr Reddy's to cater $280 mln Nigerian pharma market

New Delhi, June 15 (UNI) To serve the 280-million-dollar Nigerian pharma market, Dr Reddy's Laboratories Ltd has opened its 40th overseas office in Lagos, Nigeria in partnership with Phillips Pharmaceuticals.

The company is initially targeting therapeutic areas like gastroenterology, diabetes and cancer.

The first phase of launch will see major brands like Omez, Reclide, Diavista, Osetron and Docetere 20 mg (from amongst the range of oncology drugs) being introduced in the Nigerian market, said Mr Rajesh Kumar, Head of Ameera region.

''Our Nigerian operations based on the distributor model is a step in bringing quality and affordable medicine to people across the world. With the introduction of our leading brands, we are confident of making our presence felt among the Nigerian medical community.'' UNI